Crinetics Pharmaceuticals, Inc.

NASDAQ:CRNX

56.82 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 302.162395.92454.897142.79539.55341.19332.67230.91262.293145.548200.695161.536178.771105.57993.087117.82160.81450.91740.32666.57959.71662.83344.973169.65468.40873.7414.192-12.152
Short Term Investments 560.791505.037503.658411.858224.976254.929301.753337.45346.213174.177133.01231.78924.99145.08677.79369.00444.35161.88578.06665.09485.25894.379118.902000024.304
Cash and Short Term Investments 862.953900.961558.555554.653264.529296.122334.425368.362408.506319.725333.707193.325203.762150.665170.88186.824205.165112.802118.392131.673144.974157.212163.875169.65468.40873.7414.19212.152
Net Receivables 5.19.449.35111.6392.3822.3492.4252.3452.1111.5452.0291.041.0440.8571.8331.7691.5241.2211.3781.0480.5650.841.5840.511.2230.7380.7340
Inventory 000-11.63915.138-2.34905.9644.0425.362-2.029000-1.83300000000000.0270.1410
Other Current Assets 6.7236.8276.24721.1072.7619.2818.3341.6521.6261.6170.9129.6086.5496.2826.6125.5293.9213.1453.5692.6832.2191.0631.2240.8770.3130.2260.0980
Total Current Assets 874.776917.228574.153575.76284.81305.403345.184378.323416.285328.249344.72203.973211.355157.804177.492194.122210.61117.168123.339135.404147.758159.115166.683171.04169.94474.73115.16512.152
Non-Current Assets:
Property, Plant & Equipment, Net 57.25757.62557.4357.8064.4754.6374.9865.1584.8494.4694.7174.8865.0745.2465.4135.6956.0126.2166.4566.6056.8917.1484.2324.3531.8080.4760.40
Goodwill 0000000000000000000000000000
Intangible Assets 0000000000000000000000000000
Goodwill and Intangible Assets 0000000000000000000000000000
Long Term Investments 1.31.31.775.9711.9681.9691.9691.399346.2130.5681.010.50.50.500000000000000
Tax Assets 0000000000000000000000000000
Other Non-Current Assets 2.202222220.0370-345.61400.5680000.540.50.50.50.5820.50.50.50.51.2892.9511.1220.033-12.152
Total Non-Current Assets 60.75960.92561.265.7778.4438.6066.9926.5575.4485.0376.2955.3865.5745.7465.9536.1956.5126.7167.0387.1057.3917.6484.7325.6424.7591.5980.433-12.152
Total Assets 935.535978.153635.353641.537293.254314.009352.176384.88421.733333.286351.015209.359216.929163.55183.445200.317217.122123.884130.377142.509155.149166.763171.415176.68374.70376.32915.5980
Liabilities & Equity:
Current Liabilities:
Account Payables 8.87210.7566.5485.8424.8455.8956.8835.8779.03912.1348.4686.1537.1456.2135.5884.696.768.2965.4982.1132.7052.0031.4561.3982.6031.3350.4030
Short Term Debt 7.4455.7924.1733.9891.1091.0791.0511.0220.9930.9650.9390.9120.8860.86000000.6960.6780.665000000
Tax Payables 0000000000000000000000000000
Deferred Revenue 2.562.4632.0561.6622.082.1212.242.322.5432.706-0.939-0.912-0.886-0.8600000005.485000000
Other Current Liabilities 35.532.75631.16528.9724.57617.22617.54915.33713.544.4527.5276.2874.7744.0514.9014.1433.112.4642.8425.0734.3670.6656.4694.1163.0351.8010.4940
Total Current Liabilities 54.37751.76743.94240.46332.6126.32127.72324.55626.11520.25715.99512.4411.91910.26410.4898.8339.8710.768.347.8827.758.8187.9255.5145.6383.1360.8970
Non-Current Liabilities:
Long Term Debt 45.87346.71247.55548.1821.4561.7432.0242.32.5652.8223.0743.3223.5583.7884.0144.2344.4444.6484.8495.0445.2265.401000000
Deferred Revenue Non-Current 4.324.7414.755.1445.0725.6156.1016.6526.8887.163000000000000000000
Deferred Tax Liabilities Non-Current 00-47.555-5.144-5.072-5.615-6.101-6.652-6.888-7.163000000000000000000
Other Non-Current Liabilities 0.202-047.5555.1445.0725.6156.1016.6526.8887.1630.0020.0070.0120.0180.0230.0280.0340.0390.0490.060.0720.153.2653.64694.24293.16929.7230
Total Non-Current Liabilities 50.39551.45352.30553.3266.5287.3588.1258.9529.4539.9853.0763.3293.573.8064.0374.2624.4784.6874.8985.1045.2985.5513.2653.64694.24293.16929.7230
Total Liabilities 104.772103.2296.24793.78939.13833.67935.84833.50835.56830.24219.07115.76915.48914.0714.52613.09514.34815.44713.23812.98613.04814.36911.199.1699.8896.30530.620
Equity:
Preferred Stock 00000000000000000000000176.68392.97592.97529.717.74
Common Stock 1,625.641,595.4151,191.8311,142.218791.968768.012759.432750.564742.041615.118607.581438.063418.04339.976336.508333.151330.3219.432210.793208.578206.69204.6450.0240.0240.0020.0020.0010
Retained Earnings -794.687-720.632-653.702-593.605-536.147-485.168-439.173-394.182-352.257-309.882-275.255-244.461-216.61-190.515-167.614-145.973-127.653-111.162-93.802-79.253-64.823-52.396-43.38-34.885-27.297-21.729-16.2650
Accumulated Other Comprehensive Income/Loss -0.190.150.977-0.865-1.705-2.514-3.931-5.01-3.619-2.192-0.382-0.0120.010.0190.0250.0440.1270.1670.1480.1980.2340.1450.061-0.532-0.428-0.352-0.304-6.204
Other Total Stockholders Equity 000-1,141.3530-765.498-755.501000-607.199000-336.533000-210.941000203.5226.233-90.429-90.872-28.1540
Total Shareholders Equity 830.763874.933539.106-593.605254.116-485.168-439.173351.372386.165303.044-275.255193.59201.44149.48-167.614187.222202.774108.437-93.802129.523142.101152.394160.225167.523-25.177-19.976-15.02211.536
Total Equity 830.763874.933539.106-593.605254.116-485.168-439.173351.372386.165303.044-275.255193.59201.44149.48-167.614187.222202.774108.437-93.802129.523142.101152.394160.225167.523-25.177-19.976-15.02211.536
Total Liabilities & Shareholders Equity 935.535978.153635.353-499.816293.254-451.489-403.325384.88421.733333.286-256.184209.359216.929163.55-153.088200.317217.122123.884-80.564142.509155.149166.763171.415176.68374.70376.32915.59811.536